Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Sravani Gundarlapalli

Concepts (24)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
6
2022
3049
0.440
Why?
Neoplasm, Residual
3
2022
167
0.280
Why?
Bone Marrow
2
2022
414
0.210
Why?
Immunoconjugates
1
2022
38
0.210
Why?
Hematologic Diseases
1
2021
25
0.200
Why?
Communicable Diseases
1
2021
58
0.190
Why?
Antibodies, Monoclonal
2
2022
564
0.180
Why?
Hematopoietic Stem Cell Transplantation
1
2022
583
0.150
Why?
Prognosis
2
2021
2126
0.070
Why?
Bone Marrow Transplantation
1
2022
149
0.050
Why?
Humans
6
2022
54391
0.050
Why?
Stem Cell Transplantation
1
2022
201
0.050
Why?
Antibodies, Monoclonal, Humanized
1
2022
240
0.050
Why?
Transplantation, Autologous
1
2022
485
0.050
Why?
Radiopharmaceuticals
1
2021
242
0.050
Why?
Fluorodeoxyglucose F18
1
2021
212
0.050
Why?
Positron-Emission Tomography
1
2021
323
0.040
Why?
Survival Analysis
1
2021
736
0.040
Why?
Randomized Controlled Trials as Topic
1
2021
594
0.040
Why?
Treatment Outcome
1
2022
5612
0.020
Why?
Aged
1
2021
10060
0.020
Why?
Middle Aged
1
2021
13082
0.020
Why?
Male
1
2021
27347
0.010
Why?
Female
1
2021
28471
0.010
Why?
Gundarlapalli's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description